Join market access and commercialization executives from pharmaceutical and biotech companies with a focus on rare, genetic, and orphan diseases to explore the current commercial dynamics surrounding these unique products.
Rare Diseases and Orphan Products Breakthrough Summit NORD’s Rare Diseases and Orphan Products Breakthrough Summit is the largest and most meaningful multi-stakeholder event of its kind – historically featuring over...
Pharmaceutical and biotech companies all believe in representing the patient voice within the company.
The World Orphan Drug Congress is entering into its 7th year in November 2016. The Congress was one of the first events to bring together the full range of stakeholders...
RARE COLLECTIVE® is a trademark of Rare Collective, LLC. 